UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020773 |
|---|---|
| Receipt number | R000023862 |
| Scientific Title | Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE) |
| Date of disclosure of the study information | 2016/01/28 |
| Last modified on | 2021/02/02 11:37:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/01/28 09:41:05 | ||
| 2 | Update | 2016/06/23 14:18:55 | Recruitment status |
|
| 3 | Update | 2017/01/28 10:24:28 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2019/08/01 09:58:03 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2020/01/31 10:24:21 | Date of closure to data entry |
|
| 6 | Update | 2021/02/02 11:37:11 | Recruitment status |
